drugset / Trial / NCT00658008
A 10-week Study Evaluating the Efficacy and Safety of PD 0332334 in Patients With Generalized Anxiety Disorder (1)
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a 10-week trial that evaluates the efficacy and safety of PD 0332334 in subjects, ages from 18 to 65, with generalized anxiety disorder.
Timeline
- Start
- 2008-04
- Primary completion
- 2009-03
- Completion
- 2009-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | IMAGABALIN | Other / unclassified | 75 mg | Oral |
| Subject | IMAGABALIN | Other / unclassified | 175 mg | Oral |
| Subject | IMAGABALIN | Other / unclassified | 225 mg | Oral |
| Comparator | Paroxetine | Small molecule | 20 mg | Oral |